Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 1350 of 2400 entries
View as:

Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000955 Org: User:
Start: - End: 12/31/92 Due: 12/31/93

A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00000909 Org: User:
Start: - End: 06/30/04 Due: 06/30/05

The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir

Phase: N/A Priority: Normal
NCT ID: NCT00000898 Org: User:
Start: - End: 05/31/00 Due: 05/31/01

A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00000771 Org: User:
Start: - End: 09/30/96 Due: 09/30/97

(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC

Phase: N/A Priority: Normal
NCT ID: NCT00000679 Org: User:
Start: - End: - Due: -

A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease

Phase: N/A Priority: Normal
NCT ID: NCT00000719 Org: User:
Start: - End: 02/28/95 Due: 02/28/96

Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00000722 Org: User:
Start: - End: 06/30/91 Due: 06/30/92

A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00000725 Org: User:
Start: - End: 02/28/90 Due: 02/28/91

A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)

Phase: N/A Priority: Normal
NCT ID: NCT00000836 Org: User:
Start: - End: 08/31/98 Due: 08/31/99

A Phase I Evaluation of Azidothymidine (AZT) in Children With Acquired Immune Deficiency Syndrome (AIDS) or AIDS Related Complex (ARC)

Phase: N/A Priority: Normal
NCT ID: NCT00000701 Org: User:
Start: - End: 02/28/90 Due: 02/28/91

Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals

Phase: N/A Priority: Normal
NCT ID: NCT00000736 Org: User:
Start: - End: 02/28/95 Due: 02/28/96

A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)

Phase: N/A Priority: Normal
NCT ID: NCT00000659 Org: User:
Start: - End: - Due: -

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000636 Org: User:
Start: - End: 10/31/97 Due: 10/31/98

A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000973 Org: User:
Start: - End: 03/31/95 Due: 03/31/96

A Study of Nonoxynol-9 (N-9) and HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000926 Org: User:
Start: - End: 02/28/01 Due: 02/28/02

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Phase: N/A Priority: Normal
NCT ID: NCT00000865 Org: User:
Start: - End: 04/30/98 Due: 04/30/99

A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex

Phase: N/A Priority: Normal
NCT ID: NCT00000710 Org: User:
Start: - End: 05/31/90 Due: 05/31/91

A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible

Phase: N/A Priority: Normal
NCT ID: NCT00000939 Org: User:
Start: - End: 01/31/00 Due: 01/31/01

SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00000677 Org: User:
Start: - End: - Due: -

A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00000949 Org: User:
Start: - End: 07/31/00 Due: 07/31/01

A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00000902 Org: User:
Start: - End: 04/30/02 Due: 04/30/03

Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.

Phase: N/A Priority: Normal
NCT ID: NCT00000764 Org: User:
Start: - End: 07/31/96 Due: 07/31/97

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

Phase: N/A Priority: Normal
NCT ID: NCT00000774 Org: User:
Start: - End: 01/31/99 Due: 01/31/00

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

Phase: N/A Priority: Normal
NCT ID: NCT00000941 Org: User:
Start: - End: 03/31/02 Due: 03/31/03

A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease

Phase: N/A Priority: Normal
NCT ID: NCT00000880 Org: User:
Start: - End: 05/31/00 Due: 05/31/01